Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Battelle Laboratories – King Avenue						Print
																Related Pages
										On This Page
			Special Exposure CohortTechnical DocumentsAdvisory Board and NIOSH DiscussionsProgram Evaluation Plans and Reports (PEPs and PERs)Public CommentsDocument Archive
		
(Site Profile/Docket Number 206)
Location: Columbus, Ohio
Also Known As: Battelle Columbus Laboratories (BCL), Battelle Memorial Institute (BMI)
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Battelle Laboratories – King Avenue.
Class(es) Added to the SEC
All Atomic Weapons Employees who worked at the King Avenue facility owned by Battelle Laboratories in Columbus, Ohio, during the period from April 16, 1943, through June 30, 1956, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort
**Note:** This class was established from Petition 208
All Atomic Weapons Employees who worked at the facility owned by the Battelle Laboratories at the King Avenue site in Columbus, Ohio, during the period from July 1, 1956, through December 31, 1970, for a number of work days aggregating at least 250 work days, occurring either solely under this employment, or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort
**Note:** This class was established from Petition 229Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 208 (Apr 16, 1943 to Jun 30, 1956)
	Petition 208
Steps in Petition Process:
Petition Details:Date Received
October 25, 2012Date Qualified for Evaluation
October 29, 2012Summary of Information in Petition
**Job Titles and/or Job Duties:** All Atomic Weapons Employees who worked at the Battelle Laboratories – King Avenue facility in Columbus, Ohio
**Period of Employment:** April 16, 1943 through June 30, 1956
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
October 25, 2012 [139 KB (2 pages)](April 16, 1943 to June 30, 1956)Federal Register Notice Announcing that a Battelle Laboratories – King Avenue SEC Petition has met the Minimum Qualifications for Review and Evaluation
November 8, 2012 [87 KB (1 page)](April 16, 1943 to June 30, 1956)SEC Petition Evaluation Report
November 19, 2012 [302 KB (47 pages)](April 16, 1943 to June 30, 1956)Evaluation Report Sent to the Advisory Board
November 19, 2012(April 16, 1943 to June 30, 1956)Petition Discussed by the Advisory Board
The Advisory Board discussed this petition on December 11, 2012, during its regular meeting.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
January 31, 2013 [39 KB (2 pages)](April 16, 1943 to June 30, 1956)HHS Letters to Congress Regarding the SEC Petition
March 6, 2013 [90 KB (10 pages)](April 16, 1943 to June 30, 1956)HHS Designation of Additional Members to the SEC
**Designation:**
March 6, 2013 [44 KB (5 pages)](April 16, 1943 to June 30, 1956)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination Of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
March 26, 2013 [75 KB (1 page)](April 16, 1943 to June 30, 1956)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
April 5, 2013(April 16, 1943 to June 30, 1956)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
April 12, 2013 [97 KB (2 pages)](April 16, 1943 to June 30, 1956)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
April 5, 2013 [36 KB (1 page)](April 16, 1943 to June 30, 1956)
**Note:** This only applies if the class is added to the SEC.Petition 229 (Jul 1, 1956 to Dec 31, 1970)
	Petition 229
Steps in Petition Process:
Petition Details:Date Received
October 27, 2015Date Qualified for Evaluation
November 2, 2015Summary of Information in Petition
**Job Titles and/or Job Duties:** All Atomic Weapons Employees who worked at the facility owned by the Battelle Laboratories at the King Avenue site in Columbus, Ohio
**Period of Employment:** July 1, 1956 through December 31, 1970
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
October 27, 2015 [83 KB (2 pages)]
(July 1, 1956 through December 31, 1970)Federal Register Notice Announcing that a Battelle Laboratories – King Avenue SEC Petition has met the Minimum Qualifications for Review and Evaluation
November 13, 2015 [114 KB (1 page)]
(July 1, 1956 through December 31, 1970)SEC Petition Evaluation Report
November 2, 2015 [300 KB (41 pages)]
(July 1, 1956 through December 31, 1970)Evaluation Report Sent to the Advisory Board
November 6, 2015
(July 1, 1956 through December 31, 1970)Petition Discussed by the Advisory Board
The petition was discussed by the Advisory Board on November 18, 2015, during its regular meeting.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
January 15, 2016 [65 KB (2 pages)]
(July 1, 1956 through December 31, 1970)HHS Letters to Congress Regarding the SEC Petition
February 18, 2016 [188 KB (13 pages)]
(July 1, 1956 through December 31, 1970)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
February 18, 2016 [176 KB (5 pages)]
(July 1, 1956 through December 31, 1970)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
March 1, 2016 [61 KB (2 pages)]
(July 1, 1956 through December 31, 1970)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
March 19, 2016
(July 1, 1956 through December 31, 1970)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
March 25, 2016 [69 KB (2 pages)]
(July 1, 1956 through December 31, 1970)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
March 21, 2016 [66 KB (1 page)]
(July 1, 1956 through December 31, 1970)
**Note:** This only applies if the class is added to the SEC.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
Site Profile for Battelle Memorial Institute, King Avenue and West Jefferson Sites, Columbus, Ohio, Rev. 01 [5.6 MB (145 Pages)]
        June 27, 2016Advisory Board and NIOSH Discussions on Battelle Laboratories – King Avenue
The Battelle Laboratories – King Avenue discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Draft: SC&A’s Evaluation of ORAUT-OTIB-0049, Revision 02, “Estimating Doses for Plutonium Strongly Retained in the Lung” [1.3 MB (39 pages)]
            Contract No. 75D30119C04183
            Document No. SCA-TR-2021-PR049, Revision 0
            October 7, 2021
NIOSH/DCAS: Battelle Memorial Institute–King Avenue SEC Petition Evaluation Report SEC00229 [331 KB (22 pages)]
            Presentation at the November 18-19, 2015, Meeting of the Advisory Board on Radiation and Worker Health
NIOSH/DCAS Presentation: Battelle Memorial Institute (King Avenue) SEC Petition Evaluation Report for Petition 208 (Full Color Version) [462 KB (26 pages)]
        December 11, 2012
NIOSH/DCAS Presentation: Battelle Memorial Institute (King Avenue) SEC Petition Evaluation Report for Petition 208 (Black & White Version) [807 KB (26 pages)]
        December 11, 2012Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
DCAS-PER-075, Rev. 0: Battelle Memorial Institute TBD Revision Program Evaluation Report [230 KB (2 pages)]
            December 8, 2017
**About this Document:** Describes the effect of revision 1 to ORAUT-OTIB-0058 (Battelle Memorial Institute) on previously completed claims.
**Summary:** None of the re-evaluated doses resulted in a POC greater than 50%. NIOSH will provide the Department of Labor with the list of all the claims evaluated under this PER. NIOSH will not request the return of any claims.Public Comments on Battelle Laboratories – King Avenue Documents
How to Submit Comments
Comments on Battelle Laboratories – King Avenue Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (206) on all comments.
Comments Received
No comments on Battelle Laboratories – King Avenue have been received at this time.
Document Archive for Battelle Laboratories – King Avenue
Technical Documents
**Site Profile:**
Revised: March 26, 2010 [2.3 MB (124 Pages)]
**Revision Includes:** New site profile for the Battelle Memorial Institute sites in Columbus, Ohio (King Avenue) and West Jefferson, Ohio (West Jefferson). Incorporates formal internal and NIOSH review comments.
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue